HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HBW Market News: CHPA CFO Awarded, Olive Natural Packaging, ODS Plan, IFF South America

Executive Summary

CHAP’s Brian Green is Association TRENDS 2022 Association CFO of the Year; “Matisse-like dreamscape” In Olive Natural Packaging redesign; NIH’s ODS wants strategic plan input; and IFF innovation centers in Brazil, Chile, Colombia.

You may also be interested in...



Industry Suggests NIH Office Of Dietary Supplements Get More Current, Collaborative

Industry comments on NIH ODS strategic plan focus on persuading it to give trade associations input on its activities, specifically for fact sheets on dietary supplement topics. Stakeholders also want more dialogue with ODS and opportunity to comment on initiatives.

CHPA Urges NIH Office of Dietary Supplements To ‘Educate’ Congress, FDA On Label Database

With Congress considering mandatory supplement product listing as requested by FDA, trade group asks NIH’s Office of Dietary Supplements to share its experience building and maintaining its label database.

IFF Swings Open Door On Growing Probiotic Sales After Closing Merger With DuPont Nutrition

Two weeks after merging with probiotic ingredient leader DuPont Nutrition & Biosciences, International Flavors & Fragrances hosts first of two online conferences to help manufacturers and marketers “unlock the power of the microbiome wellness industry." 

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel